MesenCure – the life-saving Covid-19 treatment from Israel’s Bonus BioGroup (see here) also prevents a lethal inflammatory response that affects cancer patients receiving immunotherapy. In California trials MesenCure significantly reduced an overreaction of the immune system.
https://worldisraelnews.com/israeli-covid-drug-also-aids-cancer-immunotherapy-patients/